Scott Minick

Scott Minick is the founder of LXR Biotechnology, Inc. He currently holds the position of Chairman at California Pacific Medical Center and St. Luke's Hospital (California).
Additionally, he is the Executive Chairman at Aira Tech Corp.
and serves as a Director at Sorbent Therapeutics, Inc. and Goldilocks Therapeutics, Inc. Previously, he was a Venture Partner at ARCH Venture Partners LLC and Alta Berkeley LLP.
In his former roles, he served as the President, Chief Executive Officer & Director of DNIB Unwind, Inc. from 2011 to 2015.
He was also the President & Chief Executive Officer of Oncotherapeutics, Inc. and Chairman of Xcyte Therapies, Inc. Furthermore, he held the position of President, Chief Operating Officer & Director at SEQUUS Pharmaceuticals, Inc. from 1995 to 1998.
He has also served as a Director at Achaogen, Inc. and held the role of Independent Director at Chiasma, Inc. from 2007 to 2021.
Additionally, he has been an Independent Director at Alzheon, Inc. and a Director at Beth Israel Deaconess Medical Center, Inc., Anagen Therapeutics, Inc., and Limerick BioPharma, Inc. He started his career as a Principal at Baxter Healthcare Corp.
from 1981 to 1992 and also worked as a Principal at Eli Lilly & Co. He holds an MBA from Northwestern University and an undergraduate degree from the University of California San Diego.